Acute Lymphocytic Leukemia (ALL) Not Yet Recruiting Phase 1 Trials for Cytarabine (DB00987)

Back to Acute Lymphocytic Leukemia (ALL)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

Indication	Status	Phase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))	Not Yet Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02413021	The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens	Treatment	Cytarabine (DB00987) Deferasirox (DB01609)
NCT03555955	A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351	Treatment	Cytarabine (DB00987) Daunorubicin (DB00694)